Publications

Filter by year

Filter by type

Filter by year

2025

Vitiligo im Dialog –die Plenumsdiskussion

R. Sommer

Plenary discussion “Vitiligo in Dialogue” at the conference of the German Dermatological Association (DDG), Berlin, Germany.

Cumulative Life Course Impairment (CLCI): Messung der kumulierenden Lebensbelastungen bei Patienten mit Psoriasis in der Routineversorgung mit einem validierten Instrument

M. Augustin, R. Matthews, R. Warren, C. Braren-von Stülpnagel, A. Fatehi, M. Rudnik & R. Sommer

Poster presented at the conference of the German Dermatological Association (DDG), Berlin, Germany.

 

Wirksamkeit des Online-Programms „HautKompass“ zur Reduktion von Selbststigmatisierung - Ergebnisse einer randomisiert-kontrollierten Studie

J. Traxler

Oral presentation at the annual conference of the German Dermatological Association (DDG), Berlin, Germany

Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study

U. Mrowietz, R. Sommer, S. Gerdes, Z. Reguiai, W. Weger, E. Daudén, J.T. Maul, P.D. Ghislain, P.M. Laws, L. Naldi, E. De Jong, S. Mburu, V. Koscielny, E. Massana, A. Domenech, K. Gaarn du Jardin, I. Kasujee, M. Augustin

 

Psoriasis profoundly impairs patients' social, emotional, and physical condition, impacting on their overall well-being. Tildrakizumab is an interleukin-23p19 inhibitor labelled for the treatment of moderate-to-severe plaque psoriasis. The main objective of this study was to assess the effect of tildrakizumab on the overall well-being of people with psoriasis. Effectiveness, quality of life (QoL), symptomatology, treatment satisfaction, and the impact of psoriasis on the patients' partners were also evaluated.

PMID:
40605963
DOI:
https://doi.org/10.2147/ptt.s526748

Identification of Stigmatization and Relevant Predictors in People With Alopecia Areata and Androgenetic Alopecia: A Comparative Cross-sectional Study in German-speaking Countries and the USA

J. Kullab, C.F.Z. Stuhlmann, S. Ziehfreund, H. Wecker, T. Biedermann & A. Zink

Stigmatization of skin conditions like alopecia areata (AA) and androgenetic alopecia (AGA) impairs quality of life (QoL), but research is limited. The aim of this study was to compare stigmatization and QoL in individuals with AA and AGA in German-speaking (GS) and US samples and identify stigmatization predictors. 

PMID:
40026109
DOI:
https://doi.org/10.2340/actadv.v105.42278

Interdisciplinary care in immune-mediated inflammatory diseases with skin manifestations within the WHO's people-centred healthcare framework

R. Sommer, M. Augustin

Commentary on “Experience of patients and healthcare practitioners with interdisciplinary care in immune-mediated inflammatory diseases with skin manifestations: A systematic scoping review”.

PMID:
40277207
DOI:
https://doi.org/10.1111/jdv.20640

Erfassung der Lebensqualität bei Säuglingen und Kleinkindern mit Hauterkrankungen – Validierung des deutschen InToDermQoL-Fragebogens

J. Traxler, M. Augustin, R. Sommer, S. Hoffmann, R. Fölster-Holst, M. Baumeister, P. Staubach, N. da Silva Burger & H. Ott

Poster presented at the conference of the German Dermatological Association (DDG), Berlin, Germany.

Benefits and Satisfaction with Apremilast Treatment in Patients with Psoriasis Affecting the Genital Area: Secondary Analysis of the APPRECIATE Study

N. da Silva Burger, K.V. Tran, M. Typou, R. Sommer, D. Neasham, M. Cordey & M. Augustin

Plaque-type psoriasis affects the genital area in 7–42% of patients, and can impose significant quality of life (QoL) impairments. In this case, systemic treatment is recommended regardless of the affected body surface area. This real-world study compared treatment effects and patient-reported outcomes (PROs) between patients with and without genital lesions, undergoing apremilast treatment for 6 ± 1 months. Secondary analyses were conducted using data from the observational, retrospective, cross-sectional APPRECIATE study. 

PMID:
39969771
DOI:
https://doi.org/10.1007/s13555-025-01360-y

Effectiveness of a Self-Compassion Programme to Reduce Self-Stigma in Chronic Skin Diseases: the HautKompass RCT

J. Traxler, C. F. Z. Stuhlmann, N. da Silva Burger, C. Stierle, V. Djamei, A. Darzina, M. Rudnik & R. Sommer

Oral presentation presented at the European Health Psychology Society (EHPS), Groningen, the Netherlands

Skin Love – Entwicklung und Anwendung einer Methodik zur Charakterisierung des emotionalen Verhältnisses mit der Haut

M. Augustin, J. Augustin, J. Gutermuth & R. Sommer 

Poster presented at the conference of the German Dermatological Association (DDG), Berlin, Germany.

 

<< < 1 2 3 4 > >>